Zug, ZG, Switzerland

Waterfall Network Announces Integration with InfStones and Highlights Post-Mainnet Growth in AMA Recap

Waterfall Network achieves 339% TVL growth and adds 4,901 new validators in the first month post-mainnet launch; InfStones integration boosts infrastructure efficiency, reliability, and scalability Waterfall Network achieves 339% TVL growth and adds 4,901 new…

2024-08-20 07:00

Israel’s Bitcoin moment: Unlocking new economic opportunities

As global leaders adopt Bitcoin, Israel must seize the moment to lead in cryptocurrency innovation and economic growth.

2024-08-19 22:23

Timeless Triumph: 1934 Bugatti Type 59 Sports Wins Best in Show 2024, Crowned with Rolex 1908

Timeless Triumph: 1934 Bugatti Type 59 Sports Wins Best in Show 2024, Crowned with Rolex 1908Good morning, everyone! Today’s Mobile Monday and Wristwatch Wednesday converge into a celebration of two timeless icons. We’re featuring the elegant 1934 Bugatti Typ…

2024-08-19 17:20

1934 Bugatti Type 59 Sports wins Best of Show at Pebble Beach

Filed under: Bugatti,Automotive History,Classics Continue reading 1934 Bugatti Type 59 Sports wins Best of Show at Pebble Beach 1934 Bugatti Type 59 Sports wins Best of Show at Pebble Beach originally appeared on Autoblog on Mon, 19 Aug 2024 08:33:00 EDT. P…

2024-08-19 12:33

1934 Bugatti Type 59 Sports is Best of Show at 2024 Pebble Beach Concours

An unrestored 1934 Bugatti Type 59 Sports was voted Best of Show at the 2024 Pebble Beach Concours d'Elegance which ran on Sunday and closed out this year's Monterey Car Week. The car marked a couple of firsts for the prestigious awards as it was the first ti…

2024-08-19 08:45

Vanguard Group Inc. Has $4.64 Million Holdings in MoonLake Immunotherapeutics (NASDAQ:MLTX)

Vanguard Group Inc. boosted its stake in MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 25.3% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 92,298 shares of the company…

2024-08-18 08:22

MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives $78.67 Average Price Target from Brokerages

Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) have received an average rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the company, Marketbeat.com reports. Three research analysts have rated the sto…

2024-08-18 06:26

MoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Acquired by California State Teachers Retirement System

California State Teachers Retirement System increased its position in MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 2.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission…

2024-08-15 08:48

Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business Update

ZUG, Switzerland, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today announced the financ…

2024-08-14 10:50

WISeKey Partners with Venafi on Post-Quantum Encryption Services

Zug, Switzerland, Aug. 14, 2024 (GLOBE NEWSWIRE) -- WISeKey International Holding Ltd. (“WISeKey” or the “Company”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity and IoT solutions operating as a holding company, announced today…

2024-08-14 05:00